Neglected Tropical Diseases – Live Q&A with Eduardo Pisani

7 May 2013 IFPMA

7 May 2013


15:00 to 16:00




This event has now passed. To browse our upcoming events click here.

One billion people worldwide suffer from neglected tropical diseases (NTDs), affecting primarily poor people in tropical and subtropical areas of the world. These diseases kill or disable millions of people every year. The research based-pharmaceutical industry is one of many international stakeholders working to improve global health and reduce the burden of NTDs. As part of the industry’s commitment, IFPMA members have pledged to donate more than 14 billion treatments by 2020 to help eliminate or control the nine NTDs that represent more than 90% of the global NTD burden.
On May 7, 2013 at 15:00 CEST (9am EST), Global Health Progress will host a live Q&A focused on neglected tropical diseases with Eduardo Pisani, Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
We encourage those interested to submit questions in advance (send a message to @GlobalHealth using #NTDsQA or comment on the FaceBook post).
Join IFPMA DG for a live chat on NTDs on 7 May at 15.00 CET. Tweet questions beforehand using #NTDsQA or send to p.shelby(at)
May 7, 2013 at 15:00 CEST (9am EST)
Follow the discussion using #NTDsQA
Submit questions in advance by sending a message to @GlobalHealth using #NTDsQA or commenting on the FaceBook post.
Key twitter handles:
Global Health Progress – @globalhealth
Eduardo Pisani, Director General of IFPMA – @pisanie7


15:00 to 16:00

Neglected Tropical Diseases – Live Q&A with Eduardo Pisani


Eduardo Pisani Director General of IFPMA

Eduardo Pisani has served in the healthcare industry for over 20 years, in different countries and with roles of increasing responsibility in the field of international public policy and legal affairs. His most recent position was Vice-President, International Policy and Government Affairs at Bristol-Myers Squibb, which he joined in 2001. Previously, Eduardo held positions as legal counsel at Immuno AG in Belgium and Austria, at Baxter Healthcare in Belgium and Italy, and in European Policy and Government Affairs at Adamson Associates and SmithKline Beecham in Belgium. He started his career in 1989, in the marketing department of Lederle France. An Italian national, Eduardo received a degree in Law from the University of Catania, Italy, in 1987 and was admitted to the Italian Bar in 1991. He studied business administration at IMMI in Italy and at Vlerick Management School in Belgium, as well as International Relations at CERIS in Belgium.